67 related articles for article (PubMed ID: 15372482)
21. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
Barbieri E; Cammelli S; Mauro F; Perini F; Cazzola A; Neri S; Bunkheila F; Ferrari S; Brandoli V; Zinzani P; Mercuri M; Bacci G
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):760-4. PubMed ID: 15183479
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
[TBL] [Abstract][Full Text] [Related]
23. [Pediatric Hodgkin disease in south Tunisia: a study of 23 cases].
Khanfir A; Toumi N; Masmoudi A; Hdiji S; Elloumi M; Makni S; Boudaouara T; Daoud J; Frikha M
Cancer Radiother; 2007 Sep; 11(5):241-6. PubMed ID: 17611139
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's disease: a quantitative evaluation by computed tomography of tumor burden.
Torricelli P; Grimaldi PL; Fiocchi F; Federico M; Romagnoli R
Clin Imaging; 2004; 28(4):239-44. PubMed ID: 15246472
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
Smolewski P; Robak T; Krykowski E; Blasiñska-Morawiec M; Niewiadomska H; Pluzanska A; Chmielowska E; Zambrano O
Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
[TBL] [Abstract][Full Text] [Related]
26. [Stage III and VI Hodgkin's disease. Success and failure of therapeutic protocol H2 65 (author's transl)].
Jacquillat C; Auclerc G; Desprez-Curely JP; Auclerc MF; Andrieu JM; Weil M; Boiron M; Bernard J
Nouv Presse Med; 1979 Jul 14-28; 8(32):2591-5. PubMed ID: 493050
[TBL] [Abstract][Full Text] [Related]
27. [Relapse in Hodgkin lymphoma].
Filatova LV; Tarasenkova AA; Gershanovich ML; Semiglazov TIu
Vopr Onkol; 2012; 58(2):265-74. PubMed ID: 22774536
[TBL] [Abstract][Full Text] [Related]
28. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
Quiros PA; Kacinski BM; Wilson LD
Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
32. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.
Gallamini A; Hutchings M; Rigacci L; Specht L; Merli F; Hansen M; Patti C; Loft A; Di Raimondo F; D'Amore F; Biggi A; Vitolo U; Stelitano C; Sancetta R; Trentin L; Luminari S; Iannitto E; Viviani S; Pierri I; Levis A
J Clin Oncol; 2007 Aug; 25(24):3746-52. PubMed ID: 17646666
[TBL] [Abstract][Full Text] [Related]
33. TNM staging system may be superior to Lugano and Ann Arbor systems in predicting the overall survival of patients with primary gastrointestinal lymphoma.
Chang S; Shi X; Xu Z; Liu Q
J BUON; 2015; 20(3):812-9. PubMed ID: 26214635
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of pre-transplantation computed tomography and 67gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation.
Escobar IG; Alonso PT; Barrigon DC; Perez-Simon JA; Mateos Manteca MV; San Miguel Izquierdo JF
Ann Nucl Med; 2008 May; 22(4):251-60. PubMed ID: 18535875
[TBL] [Abstract][Full Text] [Related]
35. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
[TBL] [Abstract][Full Text] [Related]
36. ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Böll B; Görgen H; Fuchs M; Pluetschow A; Eich HT; Bargetzi MJ; Weidmann E; Junghanß C; Greil R; Scherpe A; Schmalz O; Eichenauer DA; von Tresckow B; Rothe A; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Apr; 31(12):1522-9. PubMed ID: 23509310
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma.
Kirita T; Shimooka H; Yamanaka Y; Tatebayashi S; Yamamoto K; Nishimine M; Sugimura M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):293-300. PubMed ID: 11250626
[TBL] [Abstract][Full Text] [Related]
38. The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma.
Witte H; Biersack H; Kopelke S; Rades D; Merz H; Bernard V; Lehnert H; Fetscher S; Gebauer N
Br J Haematol; 2019 Mar; 184(5):869-873. PubMed ID: 29785776
[No Abstract] [Full Text] [Related]
39. Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma.
Rautert R; Schinköthe T; Franklin J; Weihrauch M; Boll B; Pogge E; Bredenfeld H; Engert A; Diehl V; Re D
Leuk Lymphoma; 2008 Nov; 49(11):2091-8. PubMed ID: 19021051
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Postoperative Tumor Burden on Patients With Brain Metastases.
Aftahy AK; Barz M; Lange N; Baumgart L; Thunstedt C; Eller MA; Wiestler B; Bernhardt D; Combs SE; Jost PJ; Delbridge C; Liesche-Starnecker F; Meyer B; Gempt J
Front Oncol; 2022; 12():869764. PubMed ID: 35600394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
